Public Release: 

Press registration now open for 2018 Experimental Biology meeting

Join us in San Diego or register for virtual newsroom access

Experimental Biology 2018

BETHESDA, Md., Jan. 30, 2018 - Looking for the latest life science research advances in heart health, cancer or early stage drug development? We've got all that and more coming up at the 2018 Experimental Biology meeting (EB 2018), the premier annual meeting of five scientific societies to be held April 21-25 in San Diego. With more than 14,000 attendees and hundreds of scientific sessions, EB 2018 is a research bonanza you won't want to miss.

This year's meeting will include cutting-edge presentations on a wide array of topics, including:

  • How inflammation contributes to neurological problems
  • The microbiome's role in heart disease
  • New approaches for drug discovery
  • The future of osteoporosis treatment
  • Linking metabolism with disease

Virtual Newsroom

Whether you're in San Diego or thousands of miles away, the EB Virtual Newsroom is your one-stop shop for all our press releases, meeting information and blog posts. Those with reporter access to EurekAlert! will find embargoed press releases and multimedia at the virtual newsroom in mid-April. If you don't qualify for reporter access to EurekAlert!, you may apply to receive embargoed materials directly from EB through our Press Registration Form.

Both onsite and virtual registration are free for qualifying journalists!

Register to Attend EB: Get a free onsite press pass (deadline April 18)
Virtual Newsroom: Get press releases, multimedia & news tips online
Subscribe for Email Updates: Get monthly meeting updates & highlights
View the Preliminary Program: Get the latest information on planned scientific sessions & events

EB host societies include the American Association of Anatomists, American Physiological Society, American Society for Biochemistry and Molecular Biology, American Society for Investigative Pathology and American Society for Pharmacology & Experimental Therapeutics.

#expbio | EB on Facebook | EB on Twitter (@expbio)

###

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.